Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Diamond

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Psychopharmacology Bulletin|January 1, 1989
Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs. placebo in outpatients with major depressive disorderR L Borison, D Sinha, J W Albrecht, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 1995
Phenomenology and neurobiology of cocaine withdrawal: are they related?A Pathiraja, D Marazziti, G B Cassano, et al.
Psychopharmacology Bulletin|January 1, 1989
Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trialR L Borison, D Sinha, S Haverstock, et al.
Psychopharmacology Bulletin|January 1, 1991
A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxietyB I Diamond, H Nguyen, E O'Neal, et al.
Psychopharmacology Bulletin|January 1, 1988
Clozapine withdrawal rebound psychosisR L Borison, B I Diamond, D Sinha, et al.
Brain Research Bulletin|August 1, 1983
Treatment approaches in Gilles de la Tourette syndromeR L Borison, L Ang, W J Hamilton, et al.
Biochemical Pharmacology|January 1, 1978
Phenylethylamine and brain functionH C Sabelli, R L Borison, B I Diamond, et al.
Transactions of the American Neurological Association|January 1, 1979
Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapyW C Koller, B I Diamond, W J Weiner, et al.
Psychopharmacology|December 8, 1978
Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamineR L Borison, H C Sabelli, P J Maple, et al.
Neuropharmacology|September 1, 1980
The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agentW C Koller, W J Weiner, B I Diamond, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Psychopharmacology Bulletin|January 1, 1989
Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs. placebo in outpatients with major depressive disorderR L Borison, D Sinha, J W Albrecht, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 1995
Phenomenology and neurobiology of cocaine withdrawal: are they related?A Pathiraja, D Marazziti, G B Cassano, et al.
Psychopharmacology Bulletin|January 1, 1989
Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trialR L Borison, D Sinha, S Haverstock, et al.
Psychopharmacology Bulletin|January 1, 1991
A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxietyB I Diamond, H Nguyen, E O'Neal, et al.
Psychopharmacology Bulletin|January 1, 1988
Clozapine withdrawal rebound psychosisR L Borison, B I Diamond, D Sinha, et al.
Brain Research Bulletin|August 1, 1983
Treatment approaches in Gilles de la Tourette syndromeR L Borison, L Ang, W J Hamilton, et al.
Biochemical Pharmacology|January 1, 1978
Phenylethylamine and brain functionH C Sabelli, R L Borison, B I Diamond, et al.
Transactions of the American Neurological Association|January 1, 1979
Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapyW C Koller, B I Diamond, W J Weiner, et al.
Psychopharmacology|December 8, 1978
Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamineR L Borison, H C Sabelli, P J Maple, et al.
Neuropharmacology|September 1, 1980
The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agentW C Koller, W J Weiner, B I Diamond, et al.
Pageof 6